These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 14756475)
1. The management of local reactions due to allergen immunotherapy. Taşkapan O Ann Allergy Asthma Immunol; 2004 Jan; 92(1):94. PubMed ID: 14756475 [No Abstract] [Full Text] [Related]
3. Analysis of an unusual cluster of systemic reactions to subcutaneous specific immunotherapy with respiratory allergens in one allergy center. Scherer K; Schindler C; Arnold A; Bach S; Bircher AJ Int Arch Allergy Immunol; 2012; 157(3):318-20. PubMed ID: 22056648 [TBL] [Abstract][Full Text] [Related]
5. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases]. Malling HJ Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284 [TBL] [Abstract][Full Text] [Related]
12. [Possibilities and limitations of desensitization]. Wenz W Z Gesamte Inn Med; 1980 Jan; 35(2):91-8. PubMed ID: 6996356 [TBL] [Abstract][Full Text] [Related]
13. The history of sublingual immunotherapy. Pajno GB; Barberi S Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001 [TBL] [Abstract][Full Text] [Related]
14. Immunological responses to allergen immunotherapy. Till SJ; Durham SR Clin Allergy Immunol; 2004; 18():85-104. PubMed ID: 15042910 [No Abstract] [Full Text] [Related]
15. [Mechanisms of the effect of specific immunotherapy (hyposensitization) in atopic diseases]. Fassakhov RS; Polsacheva OV; Zebrev AI; Rakhmatullin IM Patol Fiziol Eksp Ter; 1986; (4):66-9. PubMed ID: 3540819 [No Abstract] [Full Text] [Related]
16. [Evolution of in vivo and in vitro tests during specific immunotherapy against hymenoptera venoms]. Sabbah A; Heulin MG; Soulière I Allerg Immunol (Paris); 1990 Jun; 22(6):242-7. PubMed ID: 1696102 [TBL] [Abstract][Full Text] [Related]
17. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782 [TBL] [Abstract][Full Text] [Related]
18. Allergic emergencies in the physician's office. Greenberger PA Clin Rev Allergy Immunol; 1999; 17(4):401-12. PubMed ID: 10829810 [No Abstract] [Full Text] [Related]
19. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy. Valenta R; Vrtala S; Focke-Tejkl M; Twardosz A; Swoboda I; Bugajska-Schretter A; Spitzauer S; Kraft D Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556 [No Abstract] [Full Text] [Related]
20. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]